Supreme Court restores access to abortion pill mifepristone through telehealth, mail and pharmacies
Key Points:
- The Supreme Court temporarily restored broad access to the abortion pill mifepristone, blocking a recent federal appeals court ruling that had imposed new restrictions on its distribution.
- Justice Samuel Alito's order allows women to obtain mifepristone at pharmacies or through the mail without an in-person doctor visit, maintaining rules that had been in place for several years.
- The availability of medication abortions, primarily using mifepristone and misoprostol, has mitigated the impact of abortion bans enacted by many Republican-led states following the 2022 overturning of Roe v. Wade.
- The order will remain effective for one week while the Supreme Court considers further arguments, after manufacturers of mifepristone filed emergency appeals to restore access.
- Anti-abortion groups criticized the decision, while providers of telehealth abortion services expressed relief and commitment to continuing medication abortion access nationwide.